Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other Non-Current Assets (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Other Non-Current Assets data on record, last reported at $9.2 million in Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 83.88% year-over-year to $9.2 million; the TTM value through Dec 2025 reached $9.2 million, up 83.88%, while the annual FY2025 figure was $9.2 million, 83.88% up from the prior year.
  • Other Non-Current Assets reached $9.2 million in Q4 2025 per ORGO's latest filing, down from $14.4 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $14.4 million in Q3 2025 and bottomed at $605000.0 in Q2 2021.
  • Average Other Non-Current Assets over 5 years is $4.1 million, with a median of $1.6 million recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: fell 16.9% in 2021, then soared 358.58% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $1.5 million in 2021, then fell by 1.11% to $1.5 million in 2022, then soared by 294.08% to $6.0 million in 2023, then decreased by 16.44% to $5.0 million in 2024, then soared by 83.88% to $9.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $9.2 million in Q4 2025, $14.4 million in Q3 2025, and $8.7 million in Q2 2025.